CMP : 2,899
Target Price :
Dr. Reddy’s Laboratories (DRL) posted lower than expected results for 3QFY2017.
In INR terms, the consolidated revenues came in at Rs3,707cr (v/s. Rs4,000cr
expected) v/s. Rs3,989cr in 3QFY2016, down 6.6% yoy, mainly driven by pressure
on the generic market. The global generic market with sales at Rs3,064cr (down
9.0% yoy), was mainly lea..